A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neuroblastoma, Wilm's Tumors and other Pediatric Cancers Bookmark and Share

Neuroblastoma, Wilm's Tumor and Other Pediatric Cancers

The Pediatric Oncology Program at City of Hope offers comprehensive, family-centered, leading-edge treatment for childhood, adolescent and young adult (AYA) patients with neuroblastoma, Wilms Tumor and a wide variety of other benign and malignant solid tumors that require expert care to offer the best chance of cure.

Neuroblastoma
Neuroblastoma, a cancer that develops in immature nerve cells, represents a diagnostic and treatment dilemma that requires expert understanding of the tumor’s biology. At City of Hope, our ground-breaking work in both laboratory science and patient care gives us the experience to determine whether the individual diagnosis calls for observation or for the most aggressive approach.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for neuroblastoma with treatments that include chemotherapy, autologous hematopoietic cell transplant (HCT), retinoic acid therapy and antibody therapy (anti-Ch14.18) for aggressive neuroblastoma. City of Hope scientists are working on several research initiatives to develop new therapies for neuroblastoma. Pediatric team members are collaborating on research efforts to bring these therapies to clinical practice.

Wilm's Tumor
Wilm’s tumor is a cancer of the kidney that is curable in most diagnosed children, with a survival rate of more than 90 percent. Usually only surgery and chemotherapy are needed to successfully treat Wilm’s tumor, but in difficult cases, more aggressive treatment, including radiation therapy, may be required. Our long-standing expertise in autologous hematopoietic cell transplant (HCT) enables aggressive treatment in patients with very advanced disease.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for Wilms tumor.

Other Solid Tumors
Children, adolescents and young adults can have many other types of tumors. As a National Cancer Institute-designated Comprehensive Cancer Center, City of Hope is prepared to deliver the best care available with its experienced pediatric oncology team. City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for the variety of cancers seen in children, adolescents and young adults. City of Hope offers expert treatment for the following diseases:
 
  • Germ cell tumors
  • Testicular or ovarian tumors
  • Thyroid cancer*
  • Melanoma
  • Carcinoma of head/neck, including larynx or tongue
  • Rare tumors of children, adolescents and young adults
     
*City of Hope is one of an elite few centers in Southern California offering comprehensive care with collaboration between endocrinology and pediatric oncology.
 
Neuroblastoma, Wilm’s tumor and the other tumors seen in children, adolescents and young adults require a team of experienced professionals to provide comprehensive and family-centered care.  At City of Hope, our pediatric team specializes in the treatment of children, adolescents and young adults from birth to 30 years of age. The team includes social workers; child life specialists; recreation, occupational and physical rehabilitation therapists; school reintegration specialists; nutritionists; psychologists; neuropsychologists; and spiritual care specialists.

Meet our team:
 
Clarke Anderson, M.D.
Julie DiMundo, D.O.
James F. Miser, M.D.
Jeanelle Folbrecht, Ph.D.
Natalie Kelly, Ph.D.
Alison Bell, C.P.N.P.
Lisa Gutierrez, P.N.P.
Kayla Fulginiti, M.S.W.
 
In addition to the best medical care available, we also provide access to several support programs, including:
 
  • The  Biller Patient and Family Resource Center
  • Unique support programs for adolescents and young adults (AYA) to assist with the often difficult transition into adulthood at the time of illness
  • Late effects/survivor clinic works with patients long after their treatment to identify, treat and counsel for any issue that might arise related to their life-saving treatment

Our physicians are leading research to find better treatments for children, adolescents and young adults with these tumors. For more information on our pediatric research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 

Neuroblastoma, Wilm's Tumors and other Pediatric Cancers

Neuroblastoma, Wilm's Tumor and Other Pediatric Cancers

The Pediatric Oncology Program at City of Hope offers comprehensive, family-centered, leading-edge treatment for childhood, adolescent and young adult (AYA) patients with neuroblastoma, Wilms Tumor and a wide variety of other benign and malignant solid tumors that require expert care to offer the best chance of cure.

Neuroblastoma
Neuroblastoma, a cancer that develops in immature nerve cells, represents a diagnostic and treatment dilemma that requires expert understanding of the tumor’s biology. At City of Hope, our ground-breaking work in both laboratory science and patient care gives us the experience to determine whether the individual diagnosis calls for observation or for the most aggressive approach.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for neuroblastoma with treatments that include chemotherapy, autologous hematopoietic cell transplant (HCT), retinoic acid therapy and antibody therapy (anti-Ch14.18) for aggressive neuroblastoma. City of Hope scientists are working on several research initiatives to develop new therapies for neuroblastoma. Pediatric team members are collaborating on research efforts to bring these therapies to clinical practice.

Wilm's Tumor
Wilm’s tumor is a cancer of the kidney that is curable in most diagnosed children, with a survival rate of more than 90 percent. Usually only surgery and chemotherapy are needed to successfully treat Wilm’s tumor, but in difficult cases, more aggressive treatment, including radiation therapy, may be required. Our long-standing expertise in autologous hematopoietic cell transplant (HCT) enables aggressive treatment in patients with very advanced disease.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for Wilms tumor.

Other Solid Tumors
Children, adolescents and young adults can have many other types of tumors. As a National Cancer Institute-designated Comprehensive Cancer Center, City of Hope is prepared to deliver the best care available with its experienced pediatric oncology team. City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for the variety of cancers seen in children, adolescents and young adults. City of Hope offers expert treatment for the following diseases:
 
  • Germ cell tumors
  • Testicular or ovarian tumors
  • Thyroid cancer*
  • Melanoma
  • Carcinoma of head/neck, including larynx or tongue
  • Rare tumors of children, adolescents and young adults
     
*City of Hope is one of an elite few centers in Southern California offering comprehensive care with collaboration between endocrinology and pediatric oncology.
 
Neuroblastoma, Wilm’s tumor and the other tumors seen in children, adolescents and young adults require a team of experienced professionals to provide comprehensive and family-centered care.  At City of Hope, our pediatric team specializes in the treatment of children, adolescents and young adults from birth to 30 years of age. The team includes social workers; child life specialists; recreation, occupational and physical rehabilitation therapists; school reintegration specialists; nutritionists; psychologists; neuropsychologists; and spiritual care specialists.

Meet our team:
 
Clarke Anderson, M.D.
Julie DiMundo, D.O.
James F. Miser, M.D.
Jeanelle Folbrecht, Ph.D.
Natalie Kelly, Ph.D.
Alison Bell, C.P.N.P.
Lisa Gutierrez, P.N.P.
Kayla Fulginiti, M.S.W.
 
In addition to the best medical care available, we also provide access to several support programs, including:
 
  • The  Biller Patient and Family Resource Center
  • Unique support programs for adolescents and young adults (AYA) to assist with the often difficult transition into adulthood at the time of illness
  • Late effects/survivor clinic works with patients long after their treatment to identify, treat and counsel for any issue that might arise related to their life-saving treatment

Our physicians are leading research to find better treatments for children, adolescents and young adults with these tumors. For more information on our pediatric research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • White button mushrooms seem fairly innocuous as fungi go. Unlike portabellas, they don’t center stage at the dinner table, and unlike truffles, they’re not the subject of gourmand fervor. But appearances can be deceiving when it comes to these mild-mannered Clark Kents of the food world. In a study ...
  • Doctors often recommend preventive screenings for several cancers, based on hereditary or genetic factors, but brain tumors aren’t one of them. Primary brain tumors, which originate in the brain rather than spreading from another location, seem to develop at random, and doctors have little insight into wh...
  • Stopping cancer starts with research. To that end, STOP CANCER has awarded $525,000 in grants to City of Hope for 2015, supporting innovative research projects and recognizing the institution’s leadership in advancing cancer treatment and prevention. Founded in 1988, STOP CANCER underwrites the work of le...
  • Cancer may not be the disease many people think it is. Normally, cancer is considered to be a disease in which cells multiply at an extremely high, and unusual, rate – increasing the likelihood of genetic mutations. But increasingly, leading researchers at City of Hope and elsewhere are contending that cancer i...
  • “Of all forms of inequality, injustice in the health care system is the most shocking and inhumane.” By the time the Rev. Martin Luther King Jr. spoke those words in Chicago in 1966, the Civil Rights Act had been passed, the Voting Rights Act was the law of the land and the March on Washington was […]
  • Eight years ago, Matthew Loscalzo surprised himself by accepting the offer to become City of Hope’s administrative director of the Sheri & Les Biller Patient and Family Resource Center and executive director of the Department of Supportive Care Medicine. At the time, he was administrative director of the Sc...
  • The mental fog that patients can experience after undergoing chemotherapy treatment for cancer has a name: “chemo brain.” “Many patients report hearing or reading about chemotherapy-related cognitive deficits, but few are actually prepared to deal with these changes,” said Celina Lemon, M.A., an occupational th...
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...
  • Attention, parents! Only a few serious sunburns can increase a child’s ultimate risk of skin cancer. Further, some studies suggest that ultraviolet (UV) exposure before the age of 10 is the most important factor for melanoma risk. Here skin cancer expert Jae Jung, M.D., Ph.D., assistant professor in the D...